Evaluation of N-(P-[125I]iodophenyl)meleimide for labeling monoclonal antibodies
✍ Scribed by P. C. Srivastava; F. F. Knapp Jr.; J. F. Allred; D. J. Buchsbaum
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 124 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Carbonic anhydrase IX (CA IX) is frequently expressed in human carcinomas and absent from the corresponding normal tissues. Strong induction by tumor hypoxia predisposes CA IX to serve as a target for cancer diagnostics and therapy. Here we evaluated targeting properties and pharmacokin
## Abstract Condensation of [^125^I]‐Bolton/Hunter reagent with N‐desmethylzopiclone lead to the title compound which was isolated and purified by normal phase HPLC, in combination with gamma counting detection. The introduction of the prosthetic group into the tracer precursor was proven by L‐SIMS
## Abstract The synthesis of the first high specific activity {^125^I} labelled selective H~3~ antagonist, Iodophenpropit‐ i.e., S‐[3‐(4(5)‐imidazolyl)propyl],N‐[2‐(4‐{^125^I}‐iodophenyl)ethyl]isothiourea sulfate is reported. The radiolabelled compound was prepared by Cu(I)assisted nucleophilic no